[1]Mich F, Green PH. Cognitive mpairment and functional
outcome inschizophrenia and bipolar disorder[J].J Clin Psychiatry,2006,67(9):3-8
[2]Buchanan RW, Freedman R, Javitt DC, et al. Recent
ad-vances in the development of novel pharmacological
agentsforthe treatment of cognitive impairments in schizophrenia[J].Schizophr Buii, 2007,3(5):1120-1130
[3]Bozikas VP, Kosmidis MH, Kiosseoglou G, et al. Neuropsychological profile of cognitively impaired with schizophrenia[J]. Compr Psyhiatr,2006 47:136-143
[4]Edlinger M, Hausmann A, Kemmler G, et al. Trends in
the pharmacological treatment of patientswith schizophrenia
over a 12 year observation period[J]. Schizophr Res,2005,77:25-
34
[5]Fioravanti M, Carlone O, Vitale B, et al. A meta analysis
of cognitive deficits in adults with a diagnosis of schizophrenia[J]. Neurop sychol Rev, 2005,15:73-95
[6]Philip D, Harvey, Jonathan R, et al .Treatment of cognitive impairmentt in early psychosis; a comparison of risperidone and haloperidol in a large long term[J]. Am J Psychi-atry,
